The invention refers to a method for treating steroid sensitive skin diseases in mammals, including those in need, It includes effective medical management of a compound selected from the group, which is composed of the following components: n - / (1s) - 2-amine-1 - [(3-fluorofenil) methyl] ethyl} - 5-chloro-4 - (4-chloro-1-methyl-1h-pirazol-5-il) - 2-thiophosphor-acetamide or one of its acceptable pharmaceutical salts, and compound n - (1s) - 2-amino-1 - (3), 4-difluorophenyl (methyl) ethyl} - 5-chloro-4 - (4-chloro-1-methyl-1h-pyrazol-5-il) - 2-flutamide or its pharmaceutically acceptable saltsLa invencion se refiere a un metodo para tratar las dermatosis sensibles a los esteroides en un mamifero, incluyendo un ser humano, que lo necesite, que comprende la administracion de una cantidad terapeuticamente eficaz de un compuesto seleccionado del grupo que consiste en: N-{(1S)-2-amino-1-[(3-fluorofenil)metil]etil}-5-cloro-4-(4-cloro-1-metil-1H-pirazol-5-il)-2-tiofenocarboxamida o una de sus sales farmaceuticamente aceptables, y el compuesto N-{(1S)-2-amino-1-[(3,4-difluorofenil)metil]etil}-5-cloro-4-(4-cloro-1-metil-1H-pirazol-5-il)-2-furanocarboxamida o una de sus sales farmaceuticamente aceptables, a dicho mamifero